JP2024508709A5 - - Google Patents
Info
- Publication number
- JP2024508709A5 JP2024508709A5 JP2023548578A JP2023548578A JP2024508709A5 JP 2024508709 A5 JP2024508709 A5 JP 2024508709A5 JP 2023548578 A JP2023548578 A JP 2023548578A JP 2023548578 A JP2023548578 A JP 2023548578A JP 2024508709 A5 JP2024508709 A5 JP 2024508709A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- amino acid
- antibody according
- chain
- variant
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163150488P | 2021-02-17 | 2021-02-17 | |
| US63/150,488 | 2021-02-17 | ||
| US202163249455P | 2021-09-28 | 2021-09-28 | |
| US63/249,455 | 2021-09-28 | ||
| PCT/US2022/016683 WO2022178047A1 (en) | 2021-02-17 | 2022-02-17 | Anti-cd123 binding molecules and uses thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024508709A JP2024508709A (ja) | 2024-02-28 |
| JP2024508709A5 true JP2024508709A5 (cg-RX-API-DMAC7.html) | 2025-02-21 |
Family
ID=82931699
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023548578A Pending JP2024508709A (ja) | 2021-02-17 | 2022-02-17 | 抗cd123結合分子及びその使用法 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20240076392A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4294829A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2024508709A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20230146022A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2022221633A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3205834A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL304485A (cg-RX-API-DMAC7.html) |
| MX (1) | MX2023009615A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2022178047A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4011910A1 (en) | 2014-04-03 | 2022-06-15 | IGM Biosciences, Inc. | Modified j-chain |
| PT3247728T (pt) | 2015-01-20 | 2020-07-16 | Igm Biosciences Inc | Moléculas de ligação do recetor da superfamília do fator de necrose tumoral (fnt) e utilização das mesmas |
| ES2819870T3 (es) | 2015-09-30 | 2021-04-19 | Igm Biosciences Inc | Moléculas de unión con cadena J modificada |
| PT3355913T (pt) | 2015-09-30 | 2024-12-18 | Igm Biosciences Inc | Moléculas de ligação com cadeia j modificada |
| CN111787951B (zh) | 2018-03-01 | 2025-06-17 | Igm生物科学股份有限公司 | 影响IgM血清半衰期的IgM Fc和J链突变 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2014130635A1 (en) * | 2013-02-20 | 2014-08-28 | Novartis Ag | Effective targeting of primary human leukemia using anti-cd123 chimeric antigen receptor engineered t cells |
| US20160015749A1 (en) * | 2013-03-05 | 2016-01-21 | Baylor College Of Medicine | Engager cells for immunotherapy |
| KR102357312B1 (ko) * | 2015-03-04 | 2022-02-03 | 아이쥐엠 바이오사이언스 인코포레이티드 | Cd20 결합 분자 및 그의 용도 |
| TWI790206B (zh) * | 2016-07-18 | 2023-01-21 | 法商賽諾菲公司 | 特異性結合至cd3和cd123的雙特異性抗體樣結合蛋白 |
| EP3515491A4 (en) * | 2016-09-21 | 2020-09-16 | Aptevo Research and Development LLC | CD123 BINDING PROTEINS AND RELATED COMPOSITIONS AND PROCESSES |
| US11840569B2 (en) * | 2016-11-16 | 2023-12-12 | Ablynx N.V. | T cell recruiting polypeptides capable of binding CD123 and TCR alpha/beta |
| CA3055790A1 (en) * | 2017-04-07 | 2018-10-11 | Igm Biosciences, Inc. | Modified human igm constant regions for modulation of complement-dependent cytolysis effector function |
| EP3630839A1 (en) * | 2017-06-01 | 2020-04-08 | Xencor, Inc. | Bispecific antibodies that bind cd 123 cd3 |
| CN111787951B (zh) * | 2018-03-01 | 2025-06-17 | Igm生物科学股份有限公司 | 影响IgM血清半衰期的IgM Fc和J链突变 |
| AU2019343184B2 (en) * | 2018-09-20 | 2026-04-30 | Lentigen Technology, Inc. | Compositions and methods for treating cancer with anti-CD123 immunotherapy |
| CN114040926B (zh) * | 2019-05-04 | 2025-07-29 | 印希比生物科学有限公司 | 结合cd123的多肽及其用途 |
| JP7585305B2 (ja) * | 2019-08-17 | 2024-11-18 | アイジーエム バイオサイエンシズ インコーポレイテッド | 多量体の二重特異性抗cd123結合分子及びその使用 |
-
2022
- 2022-02-17 EP EP22756876.3A patent/EP4294829A4/en active Pending
- 2022-02-17 AU AU2022221633A patent/AU2022221633A1/en active Pending
- 2022-02-17 KR KR1020237027352A patent/KR20230146022A/ko active Pending
- 2022-02-17 WO PCT/US2022/016683 patent/WO2022178047A1/en not_active Ceased
- 2022-02-17 MX MX2023009615A patent/MX2023009615A/es unknown
- 2022-02-17 US US18/261,145 patent/US20240076392A1/en active Pending
- 2022-02-17 CA CA3205834A patent/CA3205834A1/en active Pending
- 2022-02-17 JP JP2023548578A patent/JP2024508709A/ja active Pending
-
2023
- 2023-07-16 IL IL304485A patent/IL304485A/en unknown